Algernon Announces First Patient Dosed in Phase 2 IPF and Chronic Cough Human Trial of Ifenprodil

NEXT STORY
AXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19
PREV STORY
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Endocyte Reports First Quarter Financial Results and Provides Clinical and Pipeline Update

WEST LAFAYETTE, Ind., May 10, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader ...

author_avatar
NASDAQ Market News

Global $855.54 Billion Point-of-Care Data Management Software Market to 2027: Product Launches and Product Developments Driving Growth

author_avatar
NASDAQ Market News

Tyme Announces Prostate Cancer Collaboration with Dr. Mack Roach III of UCSF

NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage ...

author_avatar
NASDAQ Market News